Mini review
Conference abstractPublished 23 Nov 2012
Holistic pharma for all
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pharmaceuticals have undoubtedly contributed to increased life expectancy and better quality of life, especially in old age. Lifestyle based diseases are now better managed but factors leading to ageing and neurodegenerative diseases are yet to be understood fully. In addition to ?curing? diseases, one has to engage in locating the origin of diseases. A more holistic approach combining different systems of medicine is called for. This helps reduce overdependence and also makes treatment more affordable. In the forthcoming era of personalized medicine, low dose formulations will play a more important role. The question of affordability also has to be constantly kept in mind. Can a vitamin, for example, be prohibitively costly? Many Indian scientific organizations and companies have made great inroads in this regard. The success stories of IICT, Hyderabad, AVRO Labs.- CIPLA, Ranbaxy, ORCHID, Glenmark are noteworthy. The CSIR-OSDD initiative in combating tropical diseases and invoking telemedicine are indeed laudable.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 19 Dec 2026
The Rise of Digital Therapeutics: How Software is Transforming Patient Care in Pharma
Article · 11 Dec 2025
Blockchain in Pharma: Enhancing Transparency and Security
Perspective · 30 Sep 2025
Transforming Pharma Quality Control: Tech & QbD
Short communication · 30 Sep 2025
Navigating Evolving MedTech & Pharma Regulations
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “S. V. Eswaran”

